Vienna, Austria / 04 April 2014 – Full integration of ExacTrac® 6.1* patient positioning system by Brainlab with an Elekta linac will be demonstrated for the first time for attendees of the European Society for Radiotherapy & Oncology (ESTRO) annual meeting. The integrated system is set-up at the Medical University Vienna/General Hospital Vienna, which is providing the opportunity for an onsite visit during the ESTRO annual meeting. ExacTrac on an Elekta linear accelerator is a pioneering combination that enables clinicians to provide cancer patients with comfortable, accurate treatments.
“As a long time ExacTrac user, the system has been one of our favorite tools from the very beginning,” states Assoc. Prof. Dietmar Georg, Head of Medical Radiation Physics, Department of Radiation Oncology, Medical University Vienna/General Hospital Vienna. “All professions, including RTTs, medical physicists and radiation oncologists, love to work with it. With the Brainlab upgrade to ExacTrac 6.1* and the new Elekta linear accelerator including a robotic table, we are excited to be able to combine premium products from our esteemed partners.”
Several institutions all over the globe have already put their trust in this new Brainlab Elekta collaboration by purchasing an ExacTrac IGRT system to be installed on an Elekta linac. Soon after ESTRO 33, the companies will officially release this automated workflow, which will enable fast, intuitive and integrated patient positioning processes for cancer treatment.
“The product automation and integration simplifies and speeds up daily workflow and gives us the opportunity to maximize the benefits of both systems for our patients, including intra-fractional verification,” adds Dr. Georg. “While we continue to benefit from its versatility for advanced and high-tech treatments in general, with the new integration, ExacTrac will now also be the imaging and patient positioning solution for our non-invasive, frameless stereotactic treatments and give us high precision for cranial treatments.”
With more than 600 installations worldwide, ExacTrac is a field-proven system for supporting sub-millimetric patient positioning for patients with tumors anywhere in the brain and body. ExacTrac has especially revolutionized precise patient alignment in stereotactic treatments known as frameless cranial radiosurgery. Over one million treatments have been performed with this non-invasive stereotactic mask system that allows a time saving, patient friendly procedure without compromising treatment accuracy and without the usage of a conventional head ring.
"With our long-term partner, Medical University Vienna/General Hospital Vienna, Brainlab is set to demonstrate our fully integrated workflow with Elekta for the first time,” explains Carsten Sommerfeldt, Managing Director and Vice President Europe at Brainlab. “We are continuously striving for optimal patient care, especially with our Frameless SRS solution including the constant possibility of monitoring the target based on real time X-Ray images during treatment”.
MedUni Vienna is not only the largest medical organization in Austria, it is also one of the most important top-level research institutions in Europe and provides Europe's largest hospital, the General Hospital Vienna (AKH in Vienna), with all of its medical staff.
In its structuring and alignment MedUni Vienna relies on the "triple track" strategy. Research, education and patient care represent the three cornerstones of the university's system. This enables medical science to respond flexibly to the continually changing demands of the state and society. In the process, maintenance of health as well as therapy, abatement of symptoms and prevention of diseases stand in the foreground.
With its long history and tradition, which covers 640 years, MedUni has developed into a highly modern research institution that covers an area of 40,000 m². It employs a staff of 5,000, of which 1,800 are researchers and 1,600 are medical doctors. Each year 100,000 patients are treated as inpatients in 31 university clinics, 48,000 operations are conducted and 605,000 outpatients receive initial treatment in the day-clinics.
Brainlab, headquartered in Munich, develops, manufactures and markets software-driven medical technology, enabling access to and consistency of advanced, less invasive patient treatment.
Brainlab technology currently powers treatments in the fields of neurosurgery, orthopedics, ENT, CMF, spine, trauma and radiation therapy. Privately held since its formation in 1989, Brainlab has more than 5,000 systems installed in about 95 countries.
To learn more about Brainlab, visit www.brainlab.com or contact:
Eva Birle / Silvia Lindner
Tel.: +49 89 / 13 95 78 27 11
Fax: +49 89 / 13 95 78 27 79
E-Mail: [email protected]
* Work in progress. Not released.